abstract |
In the present invention, the pyrazole-O-glucoside derivative selected from the group consisting of the compounds (1) to (29) according to claim 1 is selected from type 1 diabetes, type 2 diabetes, impaired glucose tolerance and hyperglycemia. It relates to a pharmaceutical composition containing in combination with at least one second therapeutic agent suitable for the treatment or prevention of one or more of the conditions. Furthermore, the present invention relates to a method for preventing or treating metabolic abnormalities and related conditions. |